A Study Comparing a New Drug (Surovatamig) With Standard Radiotherapy With or Without Rituximab in Adults With Limited Stage Nodal Follicular Lymphoma
Clinical trial NCT07736950 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07736950
- Sponsor
- Australasian Leukaemia and Lymphoma Group
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2027-01-12
- Primary completion
- 2035-01-13
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.